新冠病毒信使核糖核酸疫苗在使用肿瘤坏死因子抑制剂治疗的青少年特发性关节炎青少年中的免疫原性。 - Suppr

Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors.

作者信息

Dimopoulou Dimitra, Vartzelis George, Dasoula Foteini, Tsolia Maria, Maritsi Despoina

机构信息

Infectious Diseases' Unit, Second Department of Paediatrics, 'P. & A. Kyriakou' Children's Hospital, National and Kapodistrian University, Athens, Greece

Second Department of Pediatrics, 'P. & A. Kyriakou' Children's Hospital, National and Kapodistrian University, Athens, Greece.

出版信息

Ann Rheum Dis. 2022 Apr;81(4):592-593. doi: 10.1136/annrheumdis-2021-221607. Epub 2021 Nov 29.

DOI:10.1136/annrheumdis-2021-221607

PMID:34844930

Abstract

摘要

相似文献

Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors.新冠病毒信使核糖核酸疫苗在使用肿瘤坏死因子抑制剂治疗的青少年特发性关节炎青少年中的免疫原性。

Ann Rheum Dis. 2022 Apr;81(4):592-593. doi: 10.1136/annrheumdis-2021-221607. Epub 2021 Nov 29.

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.甲氨蝶呤和糖皮质激素会削弱单剂量BNT162b2 mRNA新冠疫苗在慢性炎症性关节炎患者中的免疫原性，但抗细胞因子疗法不会。

Ann Rheum Dis. 2021 Dec;80(12):1635-1638. doi: 10.1136/annrheumdis-2021-220862. Epub 2021 Jun 25.

Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.新冠病毒mRNA疫苗在信号转导和转录激活因子1功能获得性患者中的免疫原性和安全性

J Clin Immunol. 2022 Feb;42(2):266-269. doi: 10.1007/s10875-021-01163-8. Epub 2021 Oct 31.

Immunogenicity 6 months post COVID-19 mRNA vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors.COVID-19 mRNA 疫苗接种 6 个月后，接受 TNF 抑制剂治疗的青少年特发性关节炎患者的免疫原性。

Rheumatology (Oxford). 2023 Feb 23;62(SI2):SI205-SI209. doi: 10.1093/rheumatology/keac352.

Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.实体器官移植受者完成mRNA SARS-CoV-2疫苗接种后体液免疫反应不佳。

Clin Chem. 2021 Dec 30;68(1):251-253. doi: 10.1093/clinchem/hvab149.

Safety and tolerability of the COVID-19 messenger RNA vaccine in adolescents with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors.新冠信使核糖核酸疫苗在接受肿瘤坏死因子抑制剂治疗的青少年特发性关节炎青少年中的安全性和耐受性。

Arthritis Rheumatol. 2022 Feb;74(2):365-366. doi: 10.1002/art.41977. Epub 2022 Jan 4.

Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.针对 COVID-19 的一种改良信使核糖核酸-脂质纳米颗粒候选疫苗的安全性和免疫原性：一项 1 期、剂量递增研究的结果。

Hum Vaccin Immunother. 2024 Dec 31;20(1):2408863. doi: 10.1080/21645515.2024.2408863. Epub 2024 Oct 18.

Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study.mRNA疫苗的共同临床和免疫学特征：一项比较临床研究的初步结果。

Front Immunol. 2025 Apr 10;16:1501275. doi: 10.3389/fimmu.2025.1501275. eCollection 2025.

The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial.安全性、免疫原性和异源加强用 SARS-CoV-2 mRNA 疫苗（SYS6006）在中国 18 岁及以上人群中的效果：一项随机、开放标签、阳性对照的 3 期临床试验。

Emerg Microbes Infect. 2024 Dec;13(1):2320913. doi: 10.1080/22221751.2024.2320913. Epub 2024 Feb 29.

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women.COVID-19 mRNA 疫苗在孕妇和哺乳期妇女中的免疫原性。

JAMA. 2021 Jun 15;325(23):2370-2380. doi: 10.1001/jama.2021.7563.

引用本文的文献

Immunogenicity of COVID-19 booster vaccines in children receiving immunosuppressive medications.接受免疫抑制药物治疗的儿童接种新冠病毒加强疫苗后的免疫原性。

Pediatr Res. 2025 Jul 21. doi: 10.1038/s41390-025-04174-y.

Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls.儿童自身免疫性炎症性风湿病患者和对照者对抗 SARS-CoV-2 BNT162b2 mRNA 疫苗的细胞免疫反应。

Clin Exp Immunol. 2024 Jul 12;217(2):167-172. doi: 10.1093/cei/uxae044.

The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data.美国疫苗接种运动期间免疫疗法对新冠病毒病病死率的影响：一项使用美国食品药品监督管理局不良事件报告系统和“我们的数据世界”的多学科开放数据分析

Front Pharmacol. 2023 Jun 15;14:1186404. doi: 10.3389/fphar.2023.1186404. eCollection 2023.

Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review.mRNA 和阿斯利康 COVID-19 疫苗在自身免疫性风湿病患者中的疗效和安全性：一项系统评价。

Vaccine. 2023 Jun 13;41(26):3801-3812. doi: 10.1016/j.vaccine.2023.05.048. Epub 2023 May 22.

Editorial: Vaccination in children with immune-mediated diseases.社论：免疫介导疾病患儿的疫苗接种

Front Pediatr. 2023 Apr 14;11:1192407. doi: 10.3389/fped.2023.1192407. eCollection 2023.

Safety of the COVID-19 vaccination in children with juvenile idiopathic arthritis-A observational study from two pediatric rheumatology centres in Poland.幼年特发性关节炎患儿接种新冠疫苗的安全性——来自波兰两个儿科风湿病中心的观察性研究

Front Pediatr. 2023 Mar 10;11:1103763. doi: 10.3389/fped.2023.1103763. eCollection 2023.

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry.SARS-CoV-2 疫苗在青少年炎症性风湿和肌肉骨骼疾病患者和青少年特发性关节炎成人患者中的安全性：来自 EULAR COVAX 医生报告登记处的数据。

RMD Open. 2022 Jul;8(2). doi: 10.1136/rmdopen-2022-002322.

Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis.新冠疫苗在风湿性疾病患者中的免疫原性、有效性和安全性：一项更新的系统评价与荟萃分析

Biomedicines. 2022 Apr 1;10(4):834. doi: 10.3390/biomedicines10040834.

The COVID-19 pandemic in children and young people during 2020-2021: Learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment.2020 - 2021年儿童和青少年中的新型冠状病毒肺炎疫情：了解临床表现、传播模式、病毒载量、诊断和治疗

J Glob Health. 2021 Dec 25;11:01010. doi: 10.7189/jogh.11.01010. eCollection 2021.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献